Binder profile
ZINC4095873
Virtual-screening candidate from ZINC.
Bound to: PA3947 — DNA-binding response regulator RocR
Identifiers
Database identifiers and provenance.
- Ligand ID
ZINC4095873- UniProt (similar protein)
Q9HX69- Tanimoto
- 1.000
- Target protein
- PA3947
Structure
2D representation rendered from SMILES.
Physicochemical properties
Computed with RDKit from SMILES.
Drug-likeness
Descriptor-based ADME screening flags from SMILES. These are not experimental toxicity results.
Estimated from TPSA and LogP only: TPSA ≤ 90 Ų and −1 ≤ LogP ≤ 5 are treated as a favorable small-molecule permeability screen.
- MW ≤ 500 Da 329.2
- LogP ≤ 5 -0.49
- H-bond donors ≤ 5 3
- H-bond acceptors ≤ 10 9
- Rotatable bonds ≤ 10 1
- TPSA ≤ 140 Ų 154.6
No PAINS structural alerts detected.
Chemical representations
Canonical representations for cheminformatics workflows.
Nc1nc2c(ncn2[C@H]2C[C@@H]3O[P@@](=O)(O)OC[C@H]3O2)c(=O)[nH]1Nc1nc2c(ncn2[C@H]2C[C@@H]3O[P@@](=O)(O)OC[C@H]3O2)c(=O)[nH]1
InChI=1S/C10H12N5O6P/c11-10-13-8-7(9(16)14-10)12-3-15(8)6-1-4-5(20-6)2-19-22(17,18)21-4/h3-6H,1-2H2,(H,17,18)(H3,11,13,14,16)/t4-,5+,6+/m0/s1InChI=1S/C10H12N5O6P/c11-10-13-8-7(9(16)14-10)12-3-15(8)6-1-4-5(20-6)2-19-22(17,18)21-4/h3-6H,1-2H2,(H,17,18)(H3,11,13,14,16)/t4-,5+,6+/m0/s1
YAUQFBMBBHFWIR-KVQBGUIXSA-NYAUQFBMBBHFWIR-KVQBGUIXSA-N
Provenance
Annotation context from LigQ_2, the internal TPW step that collects PDB, ChEMBL, and ZINC ligand evidence.
- Method
- LigQ sequence
- Query
- CHEMBL2398348
- Homolog
- Q9HX69
External resources
Open this ligand in third-party databases and cheminformatics tools.
- ZINC ZINC15 ZINC4095873 →
- ZINC ZINC20 ZINC4095873 →
- UniProt UniProt Q9HX69 (homolog) →
- PubChem PubChem (by InChIKey) →
- Cheminformatics SwissADME prediction →
- Cheminformatics SwissTargetPrediction →
- Web Google Scholar (search “ZINC4095873”) →
Other binders for this protein
Quick navigation to other ligands bound to PA3947.
ChEMBL 3
Compounds with measured inhibitory activity on this target (higher pchembl = more potent).
ZINC 49
Virtual screening candidates selected by structural similarity to known actives (Tanimoto ≥ 0.5).